Peter K. Bridson

402 total citations
22 papers, 298 citations indexed

About

Peter K. Bridson is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Peter K. Bridson has authored 22 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 10 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Peter K. Bridson's work include Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Chemical Synthesis and Analysis (3 papers). Peter K. Bridson is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Chemical Synthesis and Analysis (3 papers). Peter K. Bridson collaborates with scholars based in United States and United Kingdom. Peter K. Bridson's co-authors include Colin B. Reese, Wojciech T. Markiewicz, Ronald P. Mason, David Duling, Roger V. Lloyd, Xiaodong Wang, E. Jeffrey North, Daniel L. Baker, Izumi Hide and Jörg Pohl and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Molecular Pharmacology.

In The Last Decade

Peter K. Bridson

20 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter K. Bridson United States 11 167 142 36 28 26 22 298
D L Behrens United States 7 179 1.1× 78 0.5× 39 1.1× 9 0.3× 29 1.1× 10 325
Yasunori Kohchi Japan 8 89 0.5× 108 0.8× 13 0.4× 10 0.4× 29 1.1× 12 256
A. R. Hanze United States 10 154 0.9× 97 0.7× 14 0.4× 18 0.6× 19 0.7× 16 259
Gabor Butora United States 14 215 1.3× 209 1.5× 24 0.7× 40 1.4× 27 1.0× 25 435
Kevin M. Peese United States 9 295 1.8× 232 1.6× 15 0.4× 97 3.5× 41 1.6× 13 523
Teng Jiam Liak Canada 7 221 1.3× 365 2.6× 54 1.5× 7 0.3× 17 0.7× 7 478
Chien‐Shu Chen Taiwan 11 184 1.1× 194 1.4× 12 0.3× 11 0.4× 22 0.8× 23 361
Toomas Mitt United States 12 162 1.0× 264 1.9× 12 0.3× 7 0.3× 60 2.3× 14 396
Alan S. Florjancic United States 13 180 1.1× 202 1.4× 34 0.9× 10 0.4× 10 0.4× 18 410
Mark D. Prairie United States 9 358 2.1× 162 1.1× 44 1.2× 12 0.4× 12 0.5× 21 438

Countries citing papers authored by Peter K. Bridson

Since Specialization
Citations

This map shows the geographic impact of Peter K. Bridson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Bridson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Bridson more than expected).

Fields of papers citing papers by Peter K. Bridson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. Bridson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Bridson. The network helps show where Peter K. Bridson may publish in the future.

Co-authorship network of co-authors of Peter K. Bridson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Bridson. A scholar is included among the top collaborators of Peter K. Bridson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Bridson. Peter K. Bridson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
North, E. Jeffrey, Daniel A. Osborne, Peter K. Bridson, Daniel L. Baker, & Abby L. Parrill. (2009). Autotaxin structure–activity relationships revealed through lysophosphatidylcholine analogs. Bioorganic & Medicinal Chemistry. 17(9). 3433–3442. 23 indexed citations
2.
Giorgianni, Francesco, Peter K. Bridson, Brian P. Sorrentino, Jörg Pohl, & Raymond L. Blakley. (2000). Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. Biochemical Pharmacology. 60(3). 325–338. 23 indexed citations
3.
Bridson, Peter K., Lin Xu, Neli Melman, Xiao‐duo Ji, & Kenneth A. Jacobson. (1998). Synthesis AND Adenosine Receptor Affinity of 7-β-D-Ribofuranosylxanthine. Nucleosides and Nucleotides. 17(4). 759–768. 4 indexed citations
4.
Bridson, Peter K., et al.. (1996). 6-Amino-1,8-dihydroimidazo[4,5-e][1,3]diazepin-4(5H)-one, a ring expanded analogue of guanine. Journal of the Chemical Society Perkin Transactions 1. 2257–2257. 2 indexed citations
5.
Ali, Shoukath M. & Peter K. Bridson. (1996). Synthesis of Extended Carbamate and Urea Linked Thymidine Dimers1. Nucleosides and Nucleotides. 15(9). 1531–1543.
6.
Bridson, Peter K. & Xiaodong Wang. (1995). 1-Substituent Xanthines. Synthesis. 1995(7). 855–858. 15 indexed citations
7.
Bridson, Peter K. & Rekha Iyengar. (1995). Alkylation of 5-Cyanoimidazole-4-carboxamide. Heterocycles. 41(6). 1271–1271. 2 indexed citations
8.
Bridson, Peter K.. (1994). Synthesis of Deoxyazepinomycin. Heterocycles. 38(5). 1007–1007. 3 indexed citations
9.
Bridson, Peter K., et al.. (1991). 1-(5-Amino-1-β-D-Ribofuranosylimidazol-4-carbonyl)-3,5-dimethylpyrazole, a new Intermediate for the Preparation of Aicar Analogs. Nucleosides and Nucleotides. 10(1-3). 355–358. 3 indexed citations
10.
Lloyd, Roger V., et al.. (1991). Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.. Molecular Pharmacology. 40(3). 440–445. 78 indexed citations
11.
Daly, John W., Izumi Hide, & Peter K. Bridson. (1990). Imidazodiazepinediones: a new class of adenosine receptor antagonists. Journal of Medicinal Chemistry. 33(10). 2818–2821. 14 indexed citations
12.
Bridson, Peter K., et al.. (1990). Preparation of Xanthine-3-Acetic Acid and Some Derivatives. Synthetic Communications. 20(16). 2459–2467. 10 indexed citations
13.
Bridson, Peter K. & Stéphane Lambert. (1990). Imidazo[4,5-e][1,3]diazepine-4,6-dione. A novel xanthine analogue. Journal of the Chemical Society Perkin Transactions 1. 173–173. 2 indexed citations
14.
Bridson, Peter K., et al.. (1988). Cyclic homologs of xanthines.I. Imidazo[4,5‐e][1,4]diazepine‐5,8‐diones. Journal of Heterocyclic Chemistry. 25(4). 1179–1182. 14 indexed citations
15.
Bridson, Peter K., et al.. (1987). Intramolecular cyclization of ethyl ω‐(5‐amino‐4‐aminocarbonylimidazol‐1‐yl)carboxylates. Journal of Heterocyclic Chemistry. 24(4). 1155–1156. 2 indexed citations
16.
Bridson, Peter K., et al.. (1985). The reaction of 5‐aminoimidazole‐4‐carbohydrazides with orthoesters. Journal of Heterocyclic Chemistry. 22(3). 753–755. 17 indexed citations
17.
Bridson, Peter K. & Colin B. Reese. (1979). A novel method for the methylation of heterocyclic amino groups. Conversion of guanosine into its 2-N-methyl- and 2-N,2-N-dimethyl derivatives. Bioorganic Chemistry. 8(3). 339–349. 12 indexed citations
18.
Neidle, Stephen, Amritroop Achari, George M. Sheldrick, Colin B. Reese, & Peter K. Bridson. (1978). The crystal and molecular structure of 2',3',5'-tri-O-acetyl-6-O-(mesitylenesulphonyl)guanosine. Acta Crystallographica Section B. 34(9). 2794–2798. 1 indexed citations
19.
Bridson, Peter K., Wojciech T. Markiewicz, & Colin B. Reese. (1977). Conversion of guanosine into its N 2-methyl derivative. Journal of the Chemical Society Chemical Communications. 447–447. 22 indexed citations
20.
Bridson, Peter K., Wojciech T. Markiewicz, & Colin B. Reese. (1977). Acylation of 2′,3′,5′-tri-O-acetylguanosine. Journal of the Chemical Society Chemical Communications. 791–792. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026